These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2721031)
1. Natriuretic and hypotensive effects of brain natriuretic peptide in anaesthetized DOCA-salt hypertensive rats. Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K Clin Exp Pharmacol Physiol; 1989 Mar; 16(3):185-90. PubMed ID: 2721031 [TBL] [Abstract][Full Text] [Related]
2. Natriuretic and hypotensive effects of alpha-human atrial natriuretic polypeptide in anaesthetized DOCA-salt hypertensive rats. Kondo K; Kida O; Kangawa K; Matsuo H; Tanaka K Clin Exp Pharmacol Physiol; 1986 Feb; 13(2):97-101. PubMed ID: 2940041 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic and hypotensive effects of brain natriuretic peptide (BNP) in spontaneously hypertensive rats. Kita T; Kida O; Kato J; Nakamura S; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K Life Sci; 1989; 44(21):1541-5. PubMed ID: 2525217 [TBL] [Abstract][Full Text] [Related]
4. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [TBL] [Abstract][Full Text] [Related]
5. Increased plasma brain natriuretic peptide levels in DOCA-salt hypertensive rats: relation to blood pressure and cardiac concentration. Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H Biochem Biophys Res Commun; 1990 Dec; 173(2):632-8. PubMed ID: 2148083 [TBL] [Abstract][Full Text] [Related]
6. Blood pressure and renal responses to synthetic rat atrial natriuretic factor in deoxycorticosterone acetate-salt hypertension. Kohzuki M; Abe K; Yasujima M; Kasai Y; Hiwatari M; Kanazawa M; Sato M; Omata K; Kudo K; Takeuchi K Tohoku J Exp Med; 1989 Apr; 157(4):301-11. PubMed ID: 2525826 [TBL] [Abstract][Full Text] [Related]
8. Effects of brain natriuretic peptide-45, a circulating form of rat brain natriuretic peptide, in spontaneously hypertensive rats. Kita T; Kida O; Yokota N; Eto T; Minamino N; Kangawa K; Matsuo H; Tanaka K Eur J Pharmacol; 1991 Sep; 202(1):73-9. PubMed ID: 1664804 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160 [TBL] [Abstract][Full Text] [Related]
10. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats. Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Yokota N; Bruneau BG; Fernandez BE; de Bold ML; Piazza LA; Eid H; de Bold AJ Am J Hypertens; 1995 Mar; 8(3):301-10. PubMed ID: 7540847 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the action of atriopeptin III on renal function in normal and DOCA-salt hypertensive rats. Johns EJ; Rutkowski B J Hypertens; 1989 Aug; 7(8):675-82. PubMed ID: 2530272 [TBL] [Abstract][Full Text] [Related]
13. Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension. Kohno M; Horio T; Yoshiyama M; Takeda T Hypertension; 1992 Feb; 19(2):206-11. PubMed ID: 1531333 [TBL] [Abstract][Full Text] [Related]
14. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension. Wang H; McNeill JR Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. Hirata Y; Suzuki E; Hayakawa H; Matsuoka H; Sugimoto T; Kangawa K; Matsuo H J Cardiovasc Pharmacol; 1994 Feb; 23(2):283-90. PubMed ID: 7511759 [TBL] [Abstract][Full Text] [Related]
16. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722 [TBL] [Abstract][Full Text] [Related]
17. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion. Katholi RE; Naftilan AJ; Bishop SP; Oparil S Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357 [TBL] [Abstract][Full Text] [Related]
18. Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats. Schiffrin EL; St-Louis J Hypertension; 1987 May; 9(5):504-12. PubMed ID: 3032791 [TBL] [Abstract][Full Text] [Related]
19. Cardiac content of brain natriuretic peptide in DOCA salt-hypertensive rats. Yokota N; Aburaya M; Yamamoto Y; Kato J; Kitamura K; Kida O; Eto T; Minamino N; Kangawa K; Matsuo H Life Sci; 1991; 48(5):397-402. PubMed ID: 1825127 [TBL] [Abstract][Full Text] [Related]
20. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody. Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]